Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: patients, treatment, suspend, costs, higher, result, could, which, drugs, weight-loss, compounded, industry, trying, regulators, Copycats, Sales, Halts, Drugs, Obesity, Cheaper, Patients
Source: https://www.nytimes.com/2025/04/16/health/obesity-drugs-fda-compounding-wegovy-zepbound.html